awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q39041243-5F5BDE62-ECAC-423E-B877-83BB8EAD6C45
Q39041243-5F5BDE62-ECAC-423E-B877-83BB8EAD6C45
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39041243-5F5BDE62-ECAC-423E-B877-83BB8EAD6C45
Laboratory and Clinical Monitoring of Direct Acting Oral Anticoagulants: What Clinicians Need to Know.
P2860
Q39041243-5F5BDE62-ECAC-423E-B877-83BB8EAD6C45
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39041243-5F5BDE62-ECAC-423E-B877-83BB8EAD6C45
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c51eb88226a6ef367dbd3aef1687664a370ccf6c
P2860
Body weight has limited influence on the safety, tolerability, pharmacokinetics, or pharmacodynamics of rivaroxaban (BAY 59-7939) in healthy subjects.